The trademark CALCISCON was filed by CALCISCON AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on June 22, 2022, and received undefined oppositions.
Opposition Proceedings
There are undefined Oppositions claimed against trademark.
The first opposition filed on September 22, 2022 by Calcis Lienen GmbH & Co. KG on (a) Art. 8(4), (b) Likelihood of confusion. the opponent was represented by SCHINDHELM RECHTSANWALTSGESELLSCHAFT MBH and its proceedings were handled in German The second opposition filed on September 22, 2022 by Calcis Lienen GmbH & Co. KG on (a) Art. 8(4), (b) Likelihood of confusion. the opponent was represented by SCHINDHELM RECHTSANWALTSGESELLSCHAFT MBH and its proceedings were handled in German
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 17, 2024.
Goods And Services
The mark was filed in class 1 with Biochemical products, namely products in kits for the identification and diagnosis of a calcification risk in patients, or for the identification and diagnosis of cardiovascular diseases in patients, or for the identification of a phosphate toxicity in patients and Products for the identification of a calcification in a human serum sample, namely products comprising calcium and phosphate..
The mark was filed in class 5 with following description of goods:
Pharmaceutical and veterinary products, in particular reagents and drugs
Reagents and drugs for pharmaceutical uses, in particular products and kits for the identification and diagnosis of a calcification risk in patients, or for the identification and diagnosis of cardiovascular diseases in patients, or for the identification of a phosphate toxicity, in particular products for the identification of a calcification in a human serum sample, in particular products comprising calcium and phosphate, in particular for human medical use
Drugs for treating calcification, phosphate toxicity, or cardiovascular diseases in patients.
The mark was filed in class 10 with Medical apparatus and instruments, medical devices, medical analysis instruments, medical diagnosis instruments, diagnostic instruments for medical use, analytical instruments for medical use, in particular for the analysis, detection and treatment of calcification, phosphate toxicity, or cardiovascular diseases in patients.
The mark was filed in class 35 with Marketing, Product Marketing, Device Marketing, Database Marketing, online Marketing, in particular in the area of analysis and treatment of calcification, phosphate toxicity, or cardiovascular diseases.
The mark was filed in class 42 with following description of goods:
Software as a service
Providing software and hardware for scientific use, analysis, diagnostics and treatment of calcification, phosphate toxicity, or cardiovascular diseases in patients
Design and development of computer hardware and software in the field of medical, scientific, diagnostic and therapeutic application related to the measurement, analysis and the treatment of calcification, or phosphate toxicity, or cardiovascular diseases in blood, especially in a human patient and human biologicals fluids including serum samples
Pharmaceutical drug development services, in particular for drugs treating calcification, phosphate toxicity, or cardiovascular diseases, in particular for use in human patients.
The mark was filed in class 44 with following description of goods:
Consulting services in the fields of medicine, in particular human medicine, in particular consulting related to the risk of calcification of patients, or related to the risk of cardiovascular disease in patients, or to identify a phosphate toxicity
Consulting in the fields of health care and prevention
Providing information in the fields of health, health care, drugs and drug safety
Provision of diagnostic products in kits
Provision of pharmaceutical information
Medical consulting services related to therapy and diagnostics in individuals
Medical consulting services in the area of cardiovascular diseases in patients.